228 related articles for article (PubMed ID: 8568233)
1. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
[TBL] [Abstract][Full Text] [Related]
2. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation.
Dong RP; Tachibana K; Hegen M; Munakata Y; Cho D; Schlossman SF; Morimoto C
J Immunol; 1997 Dec; 159(12):6070-6. PubMed ID: 9550406
[TBL] [Abstract][Full Text] [Related]
3. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.
Blanco J; Marié I; Callebaut C; Jacotot E; Krust B; Hovanessian AG
Exp Cell Res; 1996 May; 225(1):102-11. PubMed ID: 8635502
[TBL] [Abstract][Full Text] [Related]
4. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells.
Iwaki-Egawa S; Watanabe Y; Fujimoto Y
Cell Immunol; 1997 Jun; 178(2):180-6. PubMed ID: 9225009
[TBL] [Abstract][Full Text] [Related]
5. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
Martín M; Huguet J; Centelles JJ; Franco R
J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
[TBL] [Abstract][Full Text] [Related]
6. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
[TBL] [Abstract][Full Text] [Related]
7. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
Hühn J; Olek S; Fleischer B; von Bonin A
Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
[TBL] [Abstract][Full Text] [Related]
8. Binding of adenosine deaminase to the lymphocyte surface via CD26.
De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S
Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293
[TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles.
Valenzuela A; Blanco J; Callebaut C; Jacotot E; Lluis C; Hovanessian AG; Franco R
J Immunol; 1997 Apr; 158(8):3721-9. PubMed ID: 9103436
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
[TBL] [Abstract][Full Text] [Related]
11. Cytokines regulate membrane adenosine deaminase on human activated lymphocytes.
Cordero OJ; Salgado FJ; Fernández-Alonso CM; Herrera C; Lluis C; Franco R; Nogueira M
J Leukoc Biol; 2001 Dec; 70(6):920-30. PubMed ID: 11739555
[TBL] [Abstract][Full Text] [Related]
12. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.
Pacheco R; Martinez-Navio JM; Lejeune M; Climent N; Oliva H; Gatell JM; Gallart T; Mallol J; Lluis C; Franco R
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9583-8. PubMed ID: 15983379
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells.
Herrera C; Casadó V; Ciruela F; Schofield P; Mallol J; Lluis C; Franco R
Mol Pharmacol; 2001 Jan; 59(1):127-34. PubMed ID: 11125033
[TBL] [Abstract][Full Text] [Related]
14. Regulation of adenosine receptor engagement by ecto-adenosine deaminase.
Hashikawa T; Hooker SW; Maj JG; Knott-Craig CJ; Takedachi M; Murakami S; Thompson LF
FASEB J; 2004 Jan; 18(1):131-3. PubMed ID: 14630704
[TBL] [Abstract][Full Text] [Related]
15. Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells.
Hegen M; Camerini D; Fleischer B
Cell Immunol; 1993 Feb; 146(2):249-60. PubMed ID: 7909722
[TBL] [Abstract][Full Text] [Related]
16. Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction.
Ginés S; Mariño M; Mallol J; Canela EI; Morimoto C; Callebaut C; Hovanessian A; Casadó V; Lluis C; Franco R
Biochem J; 2002 Jan; 361(Pt 2):203-9. PubMed ID: 11772392
[TBL] [Abstract][Full Text] [Related]
17. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells.
Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF
J Immunol; 1996 Mar; 156(5):1714-21. PubMed ID: 8596018
[TBL] [Abstract][Full Text] [Related]
18. Role of CD26 for CD4 memory T cell function and activation.
Dong RP; Morimoto C
Hum Cell; 1996 Sep; 9(3):153-62. PubMed ID: 9183643
[TBL] [Abstract][Full Text] [Related]
19. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
[TBL] [Abstract][Full Text] [Related]
20. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26.
Davoodi J; Kelly J; Gendron NH; MacKenzie AE
Proteomics; 2007 Jun; 7(13):2300-10. PubMed ID: 17549790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
